Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Uroš Smrdel

PhD Uroš Smrdel
no.: 20176 source: ARIS

researcher – active in research organisation
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • French
  • Reading: Fluent
  • Writing: Functional
  • Speaking: Functional
  • German
  • Reading: Fluent
  • Writing: Functional
  • Speaking: Functional
  • Dutch
  • Reading: Functional
  • Writing: Functional
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
Oncology, radiotion therapy, lung neplasms
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
223.39
A''
0
A'
20.29
A1/2
20.29
CI10
150
CImax
36
h10
8
A1
0.62
A3
0
Data for the last 5 years (citations for the last 10 years) on April 18, 2024; A3 for period 2018-2022 (update for tender in 2023: NO)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 25  229  183  7.32 
Scopus 18  245  198  11 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:20%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. L3-2622  Biological markers of risk for development, progression and treatment response in asbestos related diseases   2020 - 2023  PhD Vita Dolžan  3,233 
2. J3-2524  Minimally invasive diagnostic approaches in brain tumours using circulating cell-free nucleic acids   2020 - 2023  PhD Jože Pižem  1,805 
3. L3-8203  Serum, genetic and epigenetic markers of risk for developing, progress and treatment response in asbestos related diseases   2017 - 2020  PhD Vita Dolžan  2,983 
4. J3-2359  Genetska in terapevtska raznolikost bolnikov pri načrtovanju individualizirane terapije pljučnega raka (Slovene)   2009 - 2012  PhD Mitja Košnik  4,288 
5. L3-0449  New approaches in the treatment of lung cancer II.   2008 - 2011  PhD Matjaž Zwitter  1,956 
6. J3-6044  Nove poti zdravljenja pljučnega raka (Slovene)   2004 - 2007  PhD Matjaž Zwitter  2,763 
7. J3-5296  Model of artificial neural networks (ANN) - help for clinicians in selecting adjuvant treatment in breast cancer patients   2003 - 2005  PhD Branko Zakotnik  1,055 
8. J3-5299  Vpliv novih metod patologije in klinike na rezultate zdravljenja bolnikov s tumorji EWing/PNET (Slovene)   2003 - 2005  PhD Živa Pohar Marinšek  1,842 
9. J3-3021  Multimodality treatment for lung cancer   2002 - 2004  PhD Matjaž Zwitter  1,796 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite